AstraZeneca plc 13.1% Potential Upside Indicated by JP Morgan Cazenove

Broker Ratings

AstraZeneca plc with EPIC/TICKER LON:AZN has had its stock rating noted as ‘Reiteration’ with the recommendation being set at ‘OVERWEIGHT’ this morning by analysts at JP Morgan Cazenove. AstraZeneca plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set their target price at 9500 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 13.1% from the opening price of 8400 GBX. Over the last 30 and 90 trading days the company share price has increased 105 points and decreased 34 points respectively.
AstraZeneca plc LON:AZN has a 50 day moving average of 8,404.44 GBX and a 200 Day Moving Average share price is recorded at 8,253.41The 1 year high share price is 10120 GBX while the year low stock price is currently 5871 GBX. There are currently 1,312,307,462 shares in issue with the average daily volume traded being 1,715,181. Market capitalisation for LON:AZN is £110,155,088,360 GBP.

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp